Small ubiquitin-like modifier 4 M55V polymorphism is not associated with diabetic nephropathy in Iranian type 2 diabetes patients |
| |
| Authors: | Farhad Shahsavar Mehrzad Jafarzadeh Alireza Azargoon Mehdi Hedayati Behnam Asadifar |
| |
| Institution: | Department of Immunology, Lorestan University of Medical Sciences, Khorramabad, Iran;1.Department of Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran;2.Department of Internal Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran;3.Department of Biochemistry, Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
| |
| Abstract: | INTRODUCTION:We studied the impact of small ubiquitin-like modifier 4 (SUMO4) M55V polymorphism on susceptibility to diabetic nephropathy in Iranian type 2 diabetes patients.MATERIALS AND METHODS:The patient group consisted of 50 Iranian type 2 diabetes patients with nephropathy, and the control group consisted of 50 Iranian type 2 diabetes patients without nephropathy. Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism method for the M55V.RESULTS:The frequency of SUMO4 AA, AG, and GG genotypes were 23%, 18%, and 9% in the patient group and 10%, 22%, and 18% in the control group. There was no significant difference in frequency of SUMO4 genotypes in patients compared to controls.CONCLUSION:These findings indicate that SUMO4 M55V polymorphism is not associated with diabetic nephropathy in Iranian type 2 diabetes patients. |
| |
| Keywords: | Iranian nephropathy polymorphism small ubiquitin-like modifier 4 type 2 diabetes |
|
|
